European Urology Oncology

Slides:



Advertisements
Similar presentations
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Advertisements

Volume 72, Issue 5, Pages (November 2017)
Volume 62, Issue 3, Pages (September 2012)
Volume 65, Issue 3, Pages (March 2014)
Volume 67, Issue 6, Pages (June 2015)
Volume 63, Issue 4, Pages (April 2013)
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Volume 61, Issue 5, Pages (May 2012)
Volume 67, Issue 3, Pages (March 2015)
European Urology Oncology
Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique  Sevan Stepanian, Mayank Patel, James.
Volume 73, Issue 1, Pages (January 2018)
Volume 70, Issue 3, Pages (September 2016)
Volume 63, Issue 3, Pages e39-e40 (March 2013)
European Urology Oncology
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 68, Issue 5, Pages (November 2015)
Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis  Mohamad B. Sonbol, Belal Firwana, Talal.
Volume 65, Issue 3, Pages (March 2014)
Volume 67, Issue 3, Pages (March 2015)
European Urology Oncology
Volume 67, Issue 3, Pages (March 2015)
European Urology Oncology
European Urology Oncology
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 72, Issue 5, Pages (November 2017)
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,
Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision  Hansjörg Keller, Joachim Lehmann, Jörn Beier 
National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival 
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial  Eva Johansson,
European Urology Oncology
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography  Andrew.
Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective,
European Urology Oncology
European Urology Oncology
European Urology Oncology
What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006  Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,
European Urology Oncology
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
European Urology Oncology
European Urology Oncology
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial  Martin Nyberg, Jonas.
Christian Stief  European Urology Supplements 
Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder  Devin N. Patel, Michael Luu, Zachary.
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study  Andrew M. Erickson, Stefano Luzzago, Axel.
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas.
European Urology Oncology
The Cost to Medicare of Bladder Cancer Care
European Urology Oncology
Volume 52, Issue 1, Pages (July 2007)
Volume 53, Issue 5, Pages (May 2008)
European Urology Oncology
European Urology Oncology
European Urology Oncology
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Volume 52, Issue 1, Pages (July 2007)
Volume 51, Issue 5, Pages (May 2007)
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Presentation transcript:

European Urology Oncology Internal and External Validation of a 90-Day Percentage Erection Fullness Score Model Predicting Potency Recovery Following Robot-assisted Radical Prostatectomy  Linda M. Huynh, Douglas Skarecky, Timothy Wilson, Clayon Lau, Christian Wagner, James Porter, Jorn H. Witt, Thomas E. Ahlering  European Urology Oncology  DOI: 10.1016/j.euo.2018.08.030 Copyright © 2018 Terms and Conditions

Fig. 1 Receiver operating characteristic curve of 90-d percentage erection fullness predicting 24-mo potency. An erection fullness threshold of 25% has sensitivity of 97.3% and specificity of 87.3% for predicting recovery (area under the curve 0.870). European Urology Oncology DOI: (10.1016/j.euo.2018.08.030) Copyright © 2018 Terms and Conditions

Fig. 2 Receiver operating characteristic curve of 90-d percentage erection fullness predicting 12-mo potency. An erection fullness threshold of 25% has sensitivity of 97.3% and specificity of 87.3% for predicting recovery (area under the curve 0.801). European Urology Oncology DOI: (10.1016/j.euo.2018.08.030) Copyright © 2018 Terms and Conditions